Your best source on health and wellness news from Luxembourg
Provided by AGP
Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
May. 14, 2026
Clinical Nutrition Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | Abbott, Baxter, Lonza
EIN Presswire
Clinical Nutrition Market is estimated to valued at USD 13.97 Bn in 2026 and is expected to reach USD 21.28 Bn by 2033, growing CAGR of 6.2% from 2026 to 2033 BURLINGAME, CA, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- Overview The...
May. 13, 2026
Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service
GlobeNewswire, Inc.
NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...
May. 6, 2026
The Active Pharmaceutical Ingredient (API) Intermediate Market is projected to achieve of US $220.77 billion by 2030.
EIN Presswire
The Business Research Company’s Active Pharmaceutical Ingredient (API) Intermediate Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 6, 2026 /EINPresswire.com/ -- The active...
Apr. 30, 2026
BENELUX: NGOs highlight dire reception conditions in Belgium ― European court issues umpteenth ruling against Belgium ― NGO demands regularisation for undocumented people in Luxembourg ― Dutch senate approves one asylum law; rejects another
European Council on Refugees and Exiles (ECRE)
A new NGO report has highlighted the impacts of Belgium’s “non-reception” policy for asylum applicants in 2025 The European Court of Human Rights has once again condemned Belgium for failing to meet the basic needs of asylum applicants.
Apr. 22, 2026
ECRE Report: Study visit to Luxembourg on good practices in upholding the rights of asylum-seeking and refugee women and girls
European Council on Refugees and Exiles (ECRE)
In autumn 2025, ECRE and its partners from across Europe conducted a study visit to Luxembourg in order to examine national practices in safeguarding the rights of self-identified asylum-seeking and refugee women and girls.
Apr. 21, 2026
Minister Fajon in Luxembourg: The EU must speak out against Israel’s human rights violations
Government of Slovenia
SLOVENIA, April 21 - We must not forget the situation in Gaza and the West Bank During the discussion on the Middle East, Minister Fajon recalled the joint initiative of the foreign ministers of Slovenia, Ireland and Spain, who called for EU...
Apr. 15, 2026
Nutraceutical Excipients Market: Powering the Future of Functional Health
GlobeNewswire, Inc.
Delray Beach, FL, April 15, 2026 (GLOBE NEWSWIRE) -- According to recent report published by MarketsandMarkets, the global nutraceutical excipients market is projected to grow from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, registering...
May. 15, 2026
U Nimman Chiang Mai Champions Sustainable Hospitality and Community Engagement
EIN Presswire
Through a holistic approach, U Nimman Chiang Mai’s green vision integrates environmentally responsible practices with meaningful community engagement.
Apr. 1, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 31, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Mar. 26, 2026
ProFeel Life Establishes Itself as Switzerland's Specialist in Additive-Free Dietary Supplements
GlobeNewswire, Inc.
Collombey-Muraz, Valais (Switzerland), March 26, 2026 (GLOBE NEWSWIRE) -- ProFeel Life, a Swiss micronutrition platform and health media outlet based in Collombey, today announces the strengthening of its natural dietary supplement offering...
Mar. 25, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Mar. 18, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 17, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Mar. 11, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, March 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
May. 14, 2026
GLP-1 Receptor Agonist Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | Eli Lilly and Company, Sanofi
EIN Presswire
GLP-1 Receptor Agonist Market is estimated to valued USD 31.71 Bn in 2026 and expected USD 72.33 Bn by 2033, growing at CAGR of 12.5% from 2026 to 2033 BURLINGAME, CA, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- Overview The “GLP-1...
May. 14, 2026
Vaccine Adjuvant Market Set to Boom Rapidly, Witnessing Strong Growth Through 2033 | CSL Limited, Seppic
EIN Presswire
Vaccine Adjuvant Market is estimated to be valued at USD 1.81 Bn in 2026 and is expected to reach USD 2.13 Bn by 2033, growing CAGR of 2.34% from 2026 to 2033 BURLINGAME, CA, UNITED STATES, May 14, 2026 /EINPresswire.com/ -- Overview The...
Mar. 4, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
May. 12, 2026
Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets
GlobeNewswire, Inc.
TAMPA, Fla. and LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the grant of...
Mar. 4, 2026
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, March 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to...
Feb. 25, 2026
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
GlobeNewswire, Inc.
NEW YORK and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the...
Feb. 25, 2026
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
GlobeNewswire, Inc.
NEW YORK CITY and NEW ORLEANS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9,...
Sign up for:
Health Network Luxembourg
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.